Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-01

Clinical Trial Update: Xyrem(Sodium Oxybate) and Ambien(Zolpidem Tartrate) in the Treatment of Chronic Insomnia. [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating Xyrem (sodium oxybate) and Ambien (zolpidem tartrate) for chronic insomnia; the study was completed and results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ambien (zolpidem)
  • Xyrem (Sodium Oxybate)

Snippet

Sponsor: Stanford University | Conditions: Sleep Initiation and Maintenance Disorders | Phase 2 | Status: COMPLETED | Results posted: 2017-06-01